Biohaven Ltd has a consensus price target of $85.44, established from looking at the 49 latest analyst ratings. The last 3 analyst ratings were released from UBS, Cantor Fitzgerald, and Cantor Fitzgerald on April 23, 2024, April 18, 2024, and April 10, 2024. With an average price target of $20 between UBS, Cantor Fitzgerald, and Cantor Fitzgerald, there's an implied -48.43% downside for Biohaven Ltd from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
04/23/2024 | BHVN | Buy Now | Biohaven | $38.78 | 54.72% | UBS | Ashwani Verma | $59 → $60 | Maintains | Buy | Get Alert |
04/18/2024 | BHVN | Buy Now | Biohaven | $38.78 | — | Cantor Fitzgerald | Charles Duncan | — | Reiterates | → Overweight | Get Alert |
04/10/2024 | BHVN | Buy Now | Biohaven | $38.78 | — | Cantor Fitzgerald | Charles Duncan | — | Reiterates | → Overweight | Get Alert |
04/09/2024 | BHVN | Buy Now | Biohaven | $38.78 | 57.3% | RBC Capital | Leonid Timashev | → $61 | Reiterates | Outperform → Outperform | Get Alert |
03/04/2024 | BHVN | Buy Now | Biohaven | $38.78 | 62.46% | HC Wainwright & Co. | Douglas Tsao | $50 → $63 | Maintains | Buy | Get Alert |
03/01/2024 | BHVN | Buy Now | Biohaven | $38.78 | 57.3% | RBC Capital | Leonid Timashev | $62 → $61 | Maintains | Outperform | Get Alert |
03/01/2024 | BHVN | Buy Now | Biohaven | $38.78 | 41.83% | TD Cowen | Tyler Van Buren | $35 → $55 | Maintains | Outperform | Get Alert |
02/23/2024 | BHVN | Buy Now | Biohaven | $38.78 | 44.4% | JP Morgan | Tessa Romero | $32 → $56 | Maintains | Overweight | Get Alert |
02/16/2024 | BHVN | Buy Now | Biohaven | $38.78 | 59.88% | RBC Capital | Leonid Timashev | → $62 | Initiates | → Outperform | Get Alert |
02/06/2024 | BHVN | Buy Now | Biohaven | $38.78 | 52.14% | UBS | Ashwani Verma | → $59 | Initiates | → Buy | Get Alert |
12/22/2023 | BHVN | Buy Now | Biohaven | $38.78 | 28.93% | HC Wainwright & Co. | Douglas Tsao | → $50 | Initiates | → Buy | Get Alert |
12/08/2023 | BHVN | Buy Now | Biohaven | $38.78 | 49.56% | Baird | Brian Skorney | → $58 | Initiates | → Outperform | Get Alert |
11/20/2023 | BHVN | Buy Now | Biohaven | $38.78 | -17.48% | JP Morgan | Tessa Romero | $26 → $32 | Maintains | Overweight | Get Alert |
11/15/2023 | BHVN | Buy Now | Biohaven | $38.78 | -7.17% | Piper Sandler | Christopher Raymond | $29 → $36 | Maintains | Overweight | Get Alert |
08/16/2023 | BHVN | Buy Now | Biohaven | $38.78 | -38.11% | JP Morgan | Tessa Romero | $27 → $24 | Maintains | Overweight | Get Alert |
07/17/2023 | BHVN | Buy Now | Biohaven | $38.78 | -20.06% | Cantor Fitzgerald | Charles Duncan | → $31 | Reiterates | Overweight → Overweight | Get Alert |
06/06/2023 | BHVN | Buy Now | Biohaven | $38.78 | -27.8% | BTIG | Thomas Shrader | → $24 | Reiterates | → Buy | Get Alert |
04/04/2023 | BHVN | Buy Now | Biohaven | $38.78 | -20.06% | Cantor Fitzgerald | Charles Duncan | $27 → $31 | Maintains | Overweight | Get Alert |
01/24/2023 | BHVN | Buy Now | Biohaven | $38.78 | -38.11% | SVB Leerink | Marc Goodman | → $24 | Initiates | → Outperform | Get Alert |
The latest price target for Biohaven (NYSE: BHVN) was reported by UBS on April 23, 2024. The analyst firm set a price target for $60.00 expecting BHVN to rise to within 12 months (a possible 54.72% upside). 17 analyst firms have reported ratings in the last year.
The latest analyst rating for Biohaven (NYSE: BHVN) was provided by UBS, and Biohaven maintained their buy rating.
There is no last upgrade for Biohaven.
The last downgrade for Biohaven Ltd happened on August 19, 2022 when Piper Sandler changed their price target from N/A to N/A for Biohaven Ltd.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Biohaven, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Biohaven was filed on April 23, 2024 so you should expect the next rating to be made available sometime around April 23, 2025.
While ratings are subjective and will change, the latest Biohaven (BHVN) rating was a maintained with a price target of $59.00 to $60.00. The current price Biohaven (BHVN) is trading at is $38.78, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.